IBOV 187,206.89 ▼ 0.56% IPSA 11,220.10 ▼ 0.16% IPC MEX 63,924.77 ▼ 0.28% MERVAL 3,098,898 ▼ 1.87% COLCAP 2,589.69 ▼ 1.41% BVL PERÚ 59,373.28 ▼ 0.32% USD/BRL5.13— 0.00% USD/MXN16.96▼ 0.01% USD/CLP941.13— 0.00% USD/COP3,077▼ 0.78% USD/PEN3.35▼ 0.01% USD/ARS1,509— 0.00% USD/UYU40.26▲ 3.12% USD/PYG5,903▲ 3.35% USD/BOB11.98▼ 2.70% USD/DOP58.96▲ 0.56% USD/CRC447.55▲ 1.64% USD/GTQ7.63▲ 2.97% USD/HNL26.85▲ 0.57% USD/NIO36.62▲ 2.58% USD/VES830.41▼ 1.28% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.74▲ 2.35% EUR/BRL5.95▲ 0.25% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 187,206.89 ▼ 0.56% IPSA 11,220.10 ▼ 0.16% IPC MEX 63,924.77 ▼ 0.28% MERVAL 3,098,898 ▼ 1.87% COLCAP 2,589.69 ▼ 1.41% BVL PERÚ 59,373.28 ▼ 0.32% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Saturday, September 12, 2026

Brazil Politics - Brazil

Brazil’s public health has lowest federal spending forecast since 2012

By · November 19, 2021 · 2 min read

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “'The false peace is over' - Colombia”

Free. We send a confirmation link first — nothing arrives until you click it. Unsubscribe with one click in any edition. If you stop opening us for 30 days we stop sending by ourselves, as we assume the interest is no longer there. See our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – At a time when the public health system is still recovering from the peak in demand caused by the Covid-19 pandemic, the federal spending forecast in this area in the 2022 budget proposal is at the lowest level since 2012, according to a technical note from the Institute for Health Policy Studies (IEPS).

IEPS director of public policies Arthur Aguillar explains that despite lower demand for care in the SUS for Covid-19, as a result of vaccination, there is a repressed demand for several procedures, which fell 19% in 2020.

The IEPS alerts to the lack of sufficient resources to fund spending on primary care, in addition to the decline in investments in the area.
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

These patients’ conditions may have worsened, particularly in the case of people with chronic diseases. According to IEPS, addressing this situation in a low-resource scenario could be dramatic.

According to the institute’s survey, resources for Health total R$140.358 (US$25) billion in 2022. In recent years, the amounts have ranged between R$143.7 billion and R$159.9 billion, in figures adjusted for inflation through September 2021.

In 2012, the projected spending stood at R$149.9 billion. “We have a range of strains on the health system, with a prevalence of chronic diseases,” Aguillar says, also one of the technical note’s authors. The lack of sufficient resources could lead to a precarious service and the deterioration of the population’s health, with repercussions on the mortality rate, he says.

BASIC CARE

One of the study’s most critical points is the stagnation of resources for basic care. In the last four budget proposals, this expense fluctuated around R$25 billion, updated for inflation, with no significant increase. In 2022, this item was allocated 17% of the Ministry of Health’s total resources.

“This increases the demand for medium and high complexity care at a later stage. This increases human suffering and also the fiscal issue,” the director says, noting that these services cost more for the public system. “The cost falls on society itself.”

Another point addressed by IEPS is the drop in investments, which currently depend more on Congressional rider amendments – which may vary from year to year. In the government’s budget proposal, investments fell 77% between 2013 and 2022, from R$9.2 billion to R$2.1 billion.

According to Aguillar, unlike spending on education, which relies on the aging population “playing in its favor” to reduce the pressure, health spending should have an even greater demand for the same reason. He says it is possible to improve the current quality of spending, but stresses that this is “not enough” to solve the problem. Manuel Faria, Victor Nobre, and Renato Tasca are also authors of the technical note.

In their public statements, members of the economic team have been saying that there will be no shortage of resources for Health, particularly for the purchase of more doses of the Covid-19 vaccine.

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.